Results 41 to 50 of about 1,010,901 (298)

Serum methionine metabolites are risk factors for metastatic prostate cancer progression. [PDF]

PLoS ONE, 2011
Clinical decision for primary treatment for prostate cancer is dictated by variables with insufficient specificity. Early detection of prostate cancer likely to develop rapid recurrence could support neo-adjuvant therapeutics and adjuvant options prior ...
Sally Stabler, Tatsuki Koyama, Zhiguo Zhao, Magaly Martinez-Ferrer, Robert H Allen, Zigmund Luka, Lioudmila V Loukachevitch, Peter E Clark, Conrad Wagner, Neil A Bhowmick   +9 more
doaj   +1 more source

Genetic Interaction Analysis of TCF7L2 for Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer

, 2017
Backgroud: Accumulated evidence has demonstrated a significant role of the Wnt pathway in human prostate cancer. We hypothesize that genetic variants in the Wnt pathway effector, Transcription factor 7-like 2 (TCF7L2), may influence clinical outcomes in ...
Chen, Chien-Shu;Huang, Chao-Yuan;Huang, Shu-Pin;Lin, Victor C.;Yu, Chia-Cheng;Chang, Ta-Yuan;Bao, Bo-Ying, 黃昭淵   +1 more
core   +1 more source

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer

, 2017
Recent evidence indicates that microRNAs might participate in prostate cancer initiation, progression and treatment response. Germline variations in microRNAs might alter target gene expression and modify the efficacy of prostate cancer therapy.
Huang, Shu-Pin;Levesque, Eric;Guillemette, Chantal;Yu, Chia-Cheng;Huang, Chao-Yuan;Lin, Victor C.;Chung, I-Che;Chen, Lih-Chyang;Laverdiere, Isabelle;Lacombe, Louis;Fradet, Yves;Chang, Ta-Yuan;Lee, Hong-Zin;Juang, Shin-Hun;Bao, Bo-Ying, 黃昭淵   +1 more
core   +1 more source

Recurrence-free survival (RFS), time to first recurrence in any site, and recurrence detection rate.

, 2023
RFS in all patients with high-risk non-muscle-invasive bladder cancer (NMIBC) was evaluated using the Kaplan–Meier method (A). RFS between the highest-risk and high-risk without highest-risk groups was compared using the log-rank test (B).
Yasuhiro Hashimoto (645885), Takahiro Yoneyama (2267794), Hiroyuki Ito (339050), Masaki Momota (14599710), Chikara Ohyama (797999), Tohru Yoneyama (797993), Kazuaki Yoshikawa (186936), Yuki Tobisawa (490798), Hayato Yamamoto (2267788), Shingo Hatakeyama (797994), Kazutaka Okita (14599707), Naoki Fujita (437629)   +11 more
core   +1 more source

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma

World Journal of Surgical Oncology
Background Medullary thyroid carcinoma (MTC) is a malignant tumor with low incidence. Currently, most studies have focused on the prognostic risk factors of MTC, whatever, time kinetic and risk factors related to calcitonin normalization (CN) and ...
Fengli Guo, Guiming Fu, Fangxuan Li, Yitong Hua, Zhongyu Wang, Xiangqian Zheng, Jingzhu Zhao, Ming Gao   +7 more
doaj   +1 more source

Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre.

PLoS ONE, 2020
We report medium-term results in men receiving primary whole-gland HIFU (WG-HIFU) and following salvage treatment. One hundred and twenty-eight patients in a single hospital were enrolled.
Yen-Ting Wu, Po Hui Chiang
doaj   +1 more source

Solid Pseudopapillary Neoplasm of the Pancreas in Children and Adolescents: Expert Recommendations

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Solid pseudopapillary neoplasm of the pancreas (SPN) is a rare low‐grade malignant exocrine pancreatic tumor, mostly discovered during the second decade of life in females, with a very good prognosis, provided microscopically complete surgical excision is achieved.
Sabine Irtan, Michael Abele, Calogero Virgone, Michaela Kuhlen, Ricardo Lopez‐Almarez, Tal Ben‐Ami, Ewa Bien, Maja Cesen, Malgorzata A. Krawczyk, Andrea Ferrari, Gianni Bisogno, Yves Reguerre, Dominik T. Schneider, Louise Galmiche, Jorg Fuchs, Sarah Braungart, Bilgehan Yalcin, Ines B. Brecht, Daniel Orbach   +18 more
wiley   +1 more source

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy

, 2017
Backgroud: Increasing evidence suggests the involvement of chronic inflammation in the progression of prostate cancer, and prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase-2, catalyzes the rate-limiting steps of the pathway. We
Lee, Cheng-Hsueh;Pao, Jiunn-Bey;Lu, Te-Ling;Lee, Hong-Zin;Lee, Yung-Chin;Liu, Chia-Chu;Huang, Chao-Yuan;Lin, Victor C.;Yu, Chia-Cheng;Yin, Hsin-Ling;Huang, Shu-Pin;Bao, Bo-Ying, 黃昭淵   +1 more
core   +1 more source

Intraoperative variables, pathological data, and biochemical recurrence.

, 2020
Intraoperative variables, pathological data, and biochemical recurrence.
Ji Eun Heo (8292897), Jong Soo Lee (2380816), Hyeok Jun Goh (6162887), Young Deuk Choi (728338), Won Sik Jang (8292900)   +4 more
core   +1 more source

Distinct Adverse Clinical Outcomes of Small and Large Cribriform Patterns on Gleason 7 Prostate Cancer: A Preliminary Study

Urology Research and Practice, 2023
Objective: We aimed to evaluate the effect of large and small cribriform morphology on survival following radical prostatectomy. Methods: We included 30 patients who underwent radical prostatectomy with curative intent between 2015 and 2022.
Ozgur Kazan, Nilufer Kadioglu, Halil İbrahim Ivelik, Mehmet Sevim, Okan Alkis, Seref Coser, Ibrahim Guven Kartal, Bekir Aras   +7 more
doaj   +1 more source